Search clinical trials for: Oxaliplatin injection

Total 11459 results

Bio-Thera Solutions

Completed

Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects

Severe Asthma

China
Sixth Affiliated Hospital, Sun Yat-sen University

Recruiting

mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer (FIND)

Advanced/Metastatic Colorectal Cancer

China
Shanghai Junshi Bioscience Co., Ltd.

Not yet recruiting

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

Intrahepatic Cholangiocarcinoma

China
Sichuan University

Not yet recruiting

Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC

Combined Hepatocellular Cholangiocarcinoma
Shanghai Henlius Biotech

Recruiting

HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric Cancer

Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)

China
Astellas Pharma Global Development, Inc.

Active, not recruiting

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-Positive, HER2-Negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW)

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

United States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
Zhejiang University

Completed

Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRC

Colorectal Cancer

China
Odense University Hospital

Completed

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

C04.588.274.476.411.307

Denmark, Sweden
Jiangsu HengRui Medicine Co., Ltd.

Terminated

SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
State Key Laboratory of Cancer Biology
Shanghai Jiao Tong University School of Medicine; Tianjin Union Medical Center and other collaborators

Unknown

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

Colorectal Cancer

China
National Cancer Institute (NCI)

Completed

Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer

Colorectal Cancer | Small Intestine Cancer | Carcinoma of the Appendix

United States
Oslo University Hospital
University Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaborators

Active, not recruiting

Nordic Pancreatic Cancer Trial (NorPACT) - 1

Pancreatic Cancer

Sweden, Norway, Denmark, Finland
Fujian Shengdi Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of HRS9531 Injections in Overweight or Obese Subjects

Overweight or Obesity
Mayo Clinic

Recruiting

Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy

Facet-Mediated Low Back Pain

United States
Beijing Anzhen Hospital

Recruiting

Randomized Evaluation of Shenfu Injection to Reduce Myocardial Injury (RESTORE)

Myocardial Infarction

China
Centre Hospitalier Universitaire Vaudois

Completed

Distant Extrafascial Injection vs Subfascial Injection for Interscalene Block: Acute Pain Outcomes and Rates of Complications

Shoulder Surgery | Postoperative Analgesia | Respiratory Function | Interscalene Block | Ultrasound-guided Regional Anesthesia

Switzerland
King's College London
Guy's and St Thomas' NHS Foundation Trust

Completed

Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De) (MultiPepT1De)

Type 1 Diabetes

United Kingdom
McMaster University
HAMSMaRT; Keeping Six; YWCA Hamilton

Not yet recruiting

The Injection-Related InfectionS (IRIS) Program (IRIS)

Infections | Peer Support | Injection-related Infections | People Who Infect Drugs (PWID)

Canada
Immorna Biotherapeutics, Inc.

Recruiting

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

Malignant Solid Tumor | Cutaneous Tumor

China
Mabwell (Shanghai) Bioscience Co., Ltd.

Completed

A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection

Asthma | Atopic Dermatitis | COPD

China
Mabwell (Shanghai) Bioscience Co., Ltd.
Huashan Hospital

Completed

A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection

Staphylococcus Aureus Infection

China
Gmax Biopharm Australia Pty Ltd.
Metaclinical; Syneos Heath

Completed

A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers

Pulmonary Arterial Hypertension

Australia
Vivozon, Inc.

Completed

A Single Ascending Dose Escalation to Investigate Safety and PK of VVZ-149 Injection in Healthy Older Male Volunteers

Healthy
Universidad de León

Recruiting

Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA) (ELECLA)

Locally Advanced Colon Cancer

Spain
University of California, Irvine

Terminated

Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

Carcinoma, Transitional Cell

United States
Johannes Gutenberg University Mainz

Completed

Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction

Stomach Neoplasms | Esophageal Neoplasms

Germany
Oncology Specialists, S.C.
Sanofi-Synthelabo

Terminated

Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Minneapolis Veterans Affairs Medical Center
Sanofi

Terminated

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Neoplasms | Head and Neck Neoplasms

United States
Beijing Tiantan Hospital

Not yet recruiting

Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis (SPECIALS)

Amyotrophic Lateral Sclerosis

China
Huashan Hospital

Not yet recruiting

Evaluation of the Safety, Tolerability and Efficacy of Gene Therapy Drug for Late Onset Pompe Disease (LOPD)

Pompe Disease (Late-onset)

China
NYU Langone Health

Recruiting

UB-312 in Patients With Synucleinopathies

Parkinson Disease | Multiple System Atrophy

United States
Fujian Shengdi Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of HRS9531 Injection in Type 2 Diabetes Subjects

Type 2 Diabetes

China
Fujian Shengdi Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes

Overweight or Obesity

China
Chengdu Kanghong Biotech Co., Ltd.

Completed

Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion (CRAVE)

Central Retinal Vein Occlusion | Macular Edema

China
Beijing Zheng Ju Medical Technology Co., Ltd.

Unknown

The Randomized Controlled Clinical Trial of Kushen Injection

Lung Cancer

China
Zhejiang Kanglaite Pharmaceutical Co.Ltd
H & J CRO International, Inc.

Unknown

A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia

Cancer Cachexia

China
Vivozon, Inc.

Completed

Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection (P1_VVZ149IV)

Healthy

Korea, Republic of
LiNing

Not yet recruiting

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

Stomach Neoplasms

China
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

Ph1b/2 Study of the Safety and Efficacy of SHR-A1811 Combinations in Advanced HER2+ Gastric Cancer

HER2+ Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

China
Sun Yat-sen University

Recruiting

Sintilimab With P-GemOx Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-cell Lymphoma, Nasal Type

NK/T Cell Lymphoma Nos

China
Samsung Medical Center

Unknown

XELOX in Advanced Biliary Tract Carcinoma After Failure of Gemcitabine-based Chemotherapy

Biliary Tract Cancer

Korea, Republic of
Fudan University

Unknown

Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients

Colorectal Cancer

China
Albert Einstein College of Medicine
Sanofi

Completed

Exploratory Study Of The ERCC-1 Gene

Rectal Cancer | Colon Cancer

United States
Woman's Health University Hospital, Egypt

Unknown

Subcutaneous Sterile Water Injection for Relief of Low Back Pain

Low Back Pain
Royan Institute

Unknown

Transplantation of Autologous Cardiac Stem Cells in Ischemic Heart Failure

Heart Failure

Iran, Islamic Republic of
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Type 2 Diabetes

China
Imperial College London
ALK-Abelló A/S

Completed

Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever

Rhinitis, Allergic, Seasonal

United Kingdom
Peking University Cancer Hospital & Institute
Peking University People's Hospital; Peking Union Medical College Hospital

Recruiting

Efficacy of Postoperative Adjuvant Chemotherapy for Stage II Colon Cancer With High Risk Factors(EPAC1) (EPAC1)

Adjuvant Chemotherapy

China
Royal Marsden NHS Foundation Trust

Completed

A Phase II Study of Oxaliplatin Capecitabine and Pre-operative Radiotherapy for Patients With Locally Advanced and Inoperable Rectal Cancer

Rectal Cancer
University of Tennessee Medical Center

Completed

HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients

Septic Shock

United States

Search clinical trials for: Oxaliplatin injection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations